CHRS
Coherus Oncology, Inc.Healthcare$1.67
◆ Neutral
Mkt Cap: $250.3MFloat: 134.6MSI: 20.8%DTC: 14.0
Data as of market close Apr 7, 2026
IV Rank
-
IV Pctl
-
HV 20d
75.3%
52W Range
$1-$3
ATR(14)
$0.12
Exp. Move
±29.9%
P/C Ratio
0.15
Earnings
May 11
GEX Positive
DEX Long
Net Put Premium
Max Pain Below
Exp. Move Wide
Low Put/Call
CHRS Key Options Data
- Total GEX
- $0.00B
- Total DEX
- $0.6M
- Max Pain
- $1.50
- Expected Move
- ±29.9%
- Put/Call OI
- 0.15
- Net Premium
- $-0.0M
- Spot Price
- $1.67
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 10 | ±$0.50 | ±29.9% | $1.17 | $2.17 |
| 2026-05-15 | 38 | ±$0.50 | ±29.9% | $1.17 | $2.17 |
| 2026-08-21 | 136 | ±$0.82 | ±49.4% | $0.84 | $2.49 |
Explore CHRS options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.